¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08
±³À°ÀÏÀÚ : 2022-10-08
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ 
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 430,000¿ø      
ºñ°í »çÀü: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ȸ¿ø:25¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ºñȸ¿ø:32¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ȸ¿ø:15¸¸¿ø »çÀü: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:20¸¸¿ø »çÀü: ¿Â¶óÀÎ-ÀÇ»ç ȸ¿ø:20¸¸¿ø »çÀü: ¿Â¶óÀÎ-ÀÇ»ç ºñȸ¿ø:27¸¸¿ø »çÀü: ¿Â¶óÀÎ-ºñÀÇ»ç ȸ¿ø:10¸¸¿ø »çÀü: ¿Â¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:15¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ȸ¿ø:35¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ÀÇ»ç ºñȸ¿ø:43¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ȸ¿ø:20¸¸¿ø ÇöÀå: ¿ÀÇÁ¶óÀÎ-ºñÀÇ»ç ºñȸ¿ø:25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 09:00~09:30 Diagnosis of classic type 1 diabetes and LADA  Sang-Man Jin(Sungkyunkwan University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 09:30~10:00 Update on CGM and connected insulin pens in type 1 diabetes  Jee Hee Yoo(Yonsei Wonju University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 10:00~10:30 Highlights from the international consensus meeting on recommendations for the use of Automated Insulin Delivery (AID) technologies in clinical practice  Revital Nimri(Schneider Children¡¯s Medical Center of Israel Israel) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 10:30~11:00 Adjunctive therapy in type 1 diabetes (metformin, GLP-1RA, SGLT2i)  Jae Hyun Bae(Korea University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 11:20~12:00 Preventing type 2 diabetes: back to the future  Vanita R. Aroda(Brigham and Women¡¯s Hospital Harvard Medical School USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 12:20~13:30 Optimal clinical approach for the management of diabetes and chronic complications with SGLT2-inhibitor  Mark Cooper(Monash University Australia) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 13:30~14:00 Renal Benefit of Tirzepatide  Hiddo Lambers Heerspink(University Medical Center Groningen Netherlands) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 14:00~14:30 Cag-Sema combination  Jaehan Jeon(Kyungpook National University Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 14:30~15:00 When they go low, we go high _ GLP-1/Glucagon Dual Agonisttide  Seungjae Baek(Hanmi Pharmaceutical Korea) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 15:00~15:30 The novel GIP, GLP-1, and glucagon triple receptor agonist LY3437943: From discovery to clinical proof-of-concept  Tamer Coskun(Eli Lilly and Company USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 15:30~16:00 EASD/ESC Symposium: new perspectives on heart function and failure in diabetes  Javed Butler(University of Mississippi USA) 
±³À°½Ã°£ 10-08 ½ºÀ§½º±×·£µåÈ£ÅÚ Convention Hall A, 4F 16:00~16:30 New insights to prevention of microvascular complications?  Christoph Wanner(University Hospital Wuerzburg Germany) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ 2022 International Congress of Diabetes and Metabolism(3ÀÏÂ÷) : 2022-10-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2022-10-09
´ÙÀ½±Û (¿Â¶óÀÎ) 2022³âµµ Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤: Á¤½ÅºÐ¼®Àû Ä¡·áÀÇ ÁÖ¿ä °³³äµé°ú ÀÓ»óÀû È°¿ë 2 : 2022-10-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 62 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 85 2024-06-19
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 44 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 59 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 58 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 28 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 30 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 59 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 49 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 22 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 22 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 28 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 51 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 18 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 50 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷